P. Debourdeau

3.8k total citations · 1 hit paper
95 papers, 1.5k citations indexed

About

P. Debourdeau is a scholar working on Internal Medicine, Surgery and Emergency Medical Services. According to data from OpenAlex, P. Debourdeau has authored 95 papers receiving a total of 1.5k indexed citations (citations by other indexed papers that have themselves been cited), including 40 papers in Internal Medicine, 28 papers in Surgery and 26 papers in Emergency Medical Services. Recurrent topics in P. Debourdeau's work include Venous Thromboembolism Diagnosis and Management (40 papers), Central Venous Catheters and Hemodialysis (26 papers) and Atrial Fibrillation Management and Outcomes (11 papers). P. Debourdeau is often cited by papers focused on Venous Thromboembolism Diagnosis and Management (40 papers), Central Venous Catheters and Hemodialysis (26 papers) and Atrial Fibrillation Management and Outcomes (11 papers). P. Debourdeau collaborates with scholars based in France, United States and Spain. P. Debourdeau's co-authors include Dominique Farge, Francis Cajfinger, Alok A. Khorana, Michel Pavic, Ingrid Pabinger, Henri Bounameaux, Ajay K. Kakkar, Benjamin Brenner, Susan Solymoss and James D. Douketis and has published in prestigious journals such as Journal of Clinical Oncology, Blood and The Lancet Oncology.

In The Last Decade

P. Debourdeau

91 papers receiving 1.5k citations

Hit Papers

International clinical practice guidelines including guid... 2016 2026 2019 2022 2016 50 100 150 200
What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

  1. International clinical practice guidelines including guidance for direct oral anticoagulants in the treatment and prophylaxis of venous thromboembolism in patients with cancer
    2016 249 citations Dominique Farge, P. Debourdeau et al. profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
P. Debourdeau France 20 906 600 457 358 250 95 1.5k
B. Lorcerie France 16 598 0.7× 476 0.8× 267 0.6× 307 0.9× 229 0.9× 75 1.5k
Theodore Wun United States 21 1.4k 1.6× 865 1.4× 547 1.2× 361 1.0× 210 0.8× 42 2.4k
Florian Moik Austria 21 1.2k 1.3× 659 1.1× 262 0.6× 236 0.7× 270 1.1× 66 2.0k
Javier Trujillo‐Santos Spain 28 1.6k 1.7× 1.1k 1.9× 328 0.7× 411 1.1× 153 0.6× 68 2.1k
Tzu‐Fei Wang Canada 22 1.9k 2.1× 1.5k 2.4× 552 1.2× 463 1.3× 164 0.7× 111 2.6k
Robert Bona United States 27 1.2k 1.3× 727 1.2× 241 0.5× 834 2.3× 200 0.8× 60 2.4k
Brian R. Branchford United States 21 765 0.8× 284 0.5× 356 0.8× 246 0.7× 151 0.6× 69 1.5k
L Brisson Canada 11 897 1.0× 357 0.6× 345 0.8× 366 1.0× 153 0.6× 14 1.8k
Gilles Pernod France 27 1.6k 1.8× 1.4k 2.4× 182 0.4× 678 1.9× 127 0.5× 139 2.9k
Sergio Bertoglio Italy 20 372 0.4× 214 0.4× 660 1.4× 444 1.2× 428 1.7× 62 1.4k

Countries citing papers authored by P. Debourdeau

Since Specialization
Citations

This map shows the geographic impact of P. Debourdeau's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by P. Debourdeau with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites P. Debourdeau more than expected).

Fields of papers citing papers by P. Debourdeau

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by P. Debourdeau. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by P. Debourdeau. The network helps show where P. Debourdeau may publish in the future.

Co-authorship network of co-authors of P. Debourdeau

This figure shows the co-authorship network connecting the top 25 collaborators of P. Debourdeau. A scholar is included among the top collaborators of P. Debourdeau based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with P. Debourdeau. P. Debourdeau is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Élias, Antoine, P. Debourdeau, Olivier Espitia, et al.. (2023). Central venous catheter associated upper extremity deep vein thrombosis in cancer patients: Diagnosis and therapeutic management. Archives of cardiovascular diseases. 117(1). 72–83. 7 indexed citations
2.
Debourdeau, P., Marie‐Antoinette Sevestre, Laurent Bertoletti, et al.. (2023). Treatment of cancer-associated venous thromboembolism in patients under palliative care. Archives of cardiovascular diseases. 117(1). 94–100.
3.
Leeuw, Karina de, Luciano López‐Jiménez, Carme Font, et al.. (2021). Risk of recurrent venous thromboembolism in patients with autoimmune diseases: data from the Registro Informatizado de Enfermedad TromboEmbólica (RIETE) registry. British Journal of Haematology. 194(1). 195–199. 5 indexed citations
4.
Debourdeau, P., et al.. (2021). Venous thromboembolism associated with central venous catheters in patients with cancer: From pathophysiology to thromboprophylaxis, areas for future studies. Journal of Thrombosis and Haemostasis. 19(11). 2659–2673. 12 indexed citations
5.
Dranitsaris, George, et al.. (2017). Dalteparin or vitamin K antagonists to prevent recurrent venous thromboembolism in cancer patients: a patient-level economic analysis for France and Austria. Supportive Care in Cancer. 25(7). 2093–2102. 5 indexed citations
6.
Farge, Dominique, P. Debourdeau, A. Bura-Rivière, et al.. (2015). Fatal Events in Cancer Patients Receiving Anticoagulant Therapy for Venous Thromboembolism. Medicine. 94(32). e1235–e1235. 40 indexed citations
7.
Ouaïssi, Mehdi, Diane Mège, Laurence Panicot‐Dubois, et al.. (2015). Impact of venous thromboembolism on the natural history of pancreatic adenocarcinoma. Hepatobiliary & pancreatic diseases international. 14(4). 436–442. 27 indexed citations
8.
Boubli, Léon, P. Coloby, P. Debourdeau, et al.. (2013). Venous thromboembolism prophylaxis in patients undergoing abdominal or pelvic surgery for cancer – A real-world, prospective, observational French study: PRéOBS. Thrombosis Research. 133(6). 985–992. 15 indexed citations
9.
Bergmann, Carsten, et al.. (2012). Une cause rare de douleurs abdominales. La Revue de Médecine Interne. 33(10). 593–594. 1 indexed citations
10.
Pavic, Michel, et al.. (2011). Gravité de l’amylose AL de localisation digestive. La Revue de Médecine Interne. 32(4). e52–e54. 2 indexed citations
11.
Farge, Dominique, C. Durant, Stéphane Villiers, et al.. (2010). Lessons from French national guidelines on the treatment of venous thrombosis and central venous catheter thrombosis in cancer patients. Thrombosis Research. 125. S108–S116. 35 indexed citations
12.
Debourdeau, P., Grégoire Le Gal, Irène Kriegel, et al.. (2009). 2008 SOR guidelines for the prevention and treatment of thrombosis associated with central venous catheters in patients with cancer: report from the working group. Annals of Oncology. 20(9). 1459–1471. 95 indexed citations
13.
Ray‐Coquard, Isabelle, Sophie Dussart, Didier Mayeur, et al.. (2009). A risk model for severe anemia to select cancer patients for primary prophylaxis with epoetin α: a prospective randomized controlled trial of the ELYPSE study group. Annals of Oncology. 20(6). 1105–1112. 18 indexed citations
14.
Pasquet, F., et al.. (2008). L’érythème flagellé : une complication rare de la bléomycine. La Revue de Médecine Interne. 30(7). 637–639. 3 indexed citations
15.
Pasquet, F., et al.. (2008). Une complication rare de la gastroscopie. La Revue de Médecine Interne. 29(10). 823–824. 1 indexed citations
16.
Pavic, Michel, et al.. (2007). Granulomatoses systémiques pseudosarcoïdosiques d’étiologie déterminée et non tuberculeuse. Étude de 67 observations. La Revue de Médecine Interne. 29(1). 5–14. 9 indexed citations
17.
Pavic, Michel, et al.. (2007). Place de la pathologie granulomateuse au cours des cancers. La Revue de Médecine Interne. 29(1). 39–45. 39 indexed citations
18.
Debourdeau, P., et al.. (2007). Lipothymie récidivante inexpliquée : penser au syndrome d'hyperperméabilité capillaire idiopathique. La Revue de Médecine Interne. 28(10). 711–713. 3 indexed citations
19.
Pavic, Michel, P. Debourdeau, M. Aletti, Dominique Farge, & H Rousset. (2005). Maladie veineuse thromboembolique et cancer. La Revue de Médecine Interne. 27(4). 313–322. 9 indexed citations
20.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by B. Lorcerie Breakdown of academic impact, for papers by Theodore Wun Breakdown of academic impact, for papers by Florian Moik Breakdown of academic impact, for papers by Javier Trujillo‐Santos Breakdown of academic impact, for papers by Tzu‐Fei Wang Breakdown of academic impact, for papers by Robert Bona Breakdown of academic impact, for papers by Brian R. Branchford Breakdown of academic impact, for papers by L Brisson Breakdown of academic impact, for papers by Gilles Pernod Breakdown of academic impact, for papers by Sergio Bertoglio
Rankless by CCL
2026